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Objectives   The aim of this study was to evaluate the effectiveness of individual placement and support (IPS) for 
people struggling with work participation due to moderate-to-severe mental illness. The study was conducted in 
Norway, a setting characterized by a comprehensive welfare system and strong employment protection legislation.
Methods   A randomized controlled multicenter trial including 410 participants was conducted. The intervention 
group received IPS according to the IPS manual. The control group received high-quality usual care. The main 
outcome was competitive employment at 12- and 18-months follow-up, based on objective registry data. Changes 
in mental health and health-related quality of life were secondary outcomes.
Results   At 12-months follow-up, 36.6% of participants in the IPS group and 27.1% of participants in the con-
trol group were in competitive employment, while the difference was slightly higher (37.4% versus 27.1%) at 
18-months follow-up. Furthermore, IPS yielded positive effects on all the secondary outcomes compared to the 
control group (all P<0.05).
Conclusions   The IPS model of supported employment was superior to high-quality usual care on both voca-
tional and non-vocational outcomes for people with moderate-to-severe mental illness, even in a policy context 
characterized by high job security and a comprehensive welfare system.
Key terms   depression; employment; mental health; psychosis; occupational rehabilitation; randomized controlled 
trial; RCT; rehabilitation; severe mental illness; supported employment.
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Mental illness constitutes a substantial burden of disease 
to a large part through its major impact on years lived 
with disability (1). Relative to many other disabling ill-
nesses, it disproportionally affects individuals of working 
age and is the major cause of social security disability 
benefits and work disability in the US as well as Europe 
(2–4). Individual placement and support (IPS) is a model 
of vocational rehabilitation that aims to help people with 
severe mental illness obtain and maintain competitive 
employment in ordinary jobs (5). IPS follows a strict 
manual to secure integration of supported employment 
with psychological treatment. The following eight prin-
ciples are incorporated in the approach to vocational 
rehabilitation: (i) eligibility based on the patient’s own 
choice, (ii) focus on competitive employment, (iii) inte-
gration between mental health and employment services, 
(iv) job support guided by the patient's preferences, (v) 
financial counseling about social security benefits, (vi) 
rapid job search initiation, (vii) employment specialists’ 
engagement in systematic job development, and (viii) 
individualized and continuous job support (6). The model 
has demonstrated successful results in 23 randomized 
controlled trials (RCT) worldwide (7, 8), and in the US 
and elsewhere, governments have taken steps to encour-
age the expansion of IPS (8, 9).
In the current study, we present the results of a large 
multicenter RCT from Norway, a policy context with 
high job security, low unemployment, and a comprehen-
sive welfare system. The trial was commissioned as a 
collaboration between the Directorate of Health and the 
Directorate of Labor and Welfare as part of a national 
initiative to implement IPS on a large scale.
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The aim of the study was to evaluate the effect 
of IPS compared to high-quality treatment as usual 
offered to people with moderate-to-severe mental ill-
ness. The main outcome was competitive employment 
rate, derived from objective registry data with no loss 
to follow-up. Secondary outcomes were levels of self-
reported psychological distress, somatic symptoms, 
functioning, well-being and quality of life. The study 
further involved multiple sites from both rural and urban 
areas, had a high number of participants, and long-term 
follow-up for the main outcome.
Methods
Design and setting
The trial was a multicenter RCT comparing IPS to high-
quality treatment as usual offered to people with moder-
ate-to-severe mental illness. Participants were recruited to 
any of the six IPS centers from regional primary and sec-
ondary mental healthcare settings while they were under-
going treatment for moderate-to-severe mental illness. 
To be eligible for participation, patients were required to 
have at least one diagnosed psychiatric disorder (10). Par-
ticipants also had to be currently out of the labor market 
but with an expressed desire to work. The only exclusion 
criterion was insufficient Norwegian language skills to 
answer the questionnaires. Inclusion started on 1 October 
2013 and ended on 31 October 2014. The detailed study 
protocol is published and available online (11).
Interventions
Participants were randomized to one of two interventions: 
(i) IPS, following the structured and manualized approach 
focused on competitive employment, or (ii) a high-quality 
version of treatment as usual, which involved a prioritized 
spot in a vocational rehabilitation scheme, primarily work 
with assistance and/or a traineeship in a sheltered busi-
ness. While IPS follows a "place-and-train" approach to 
vocational rehabilitation, the intervention schemes in the 
control condition were more in line with a "train-and-
place" approach to vocational rehabilitation (11). These 
interventions, although they also aim to promote com-
petitive employment, are based on stepwise approaches 
including prevocational training and non-competitive 
work in the process. In work with assistance, clients are 
assigned a personal facilitator who provides support to 
find a suitable job using various subsidized schemes and 
employer incentives on the way to competitive employ-
ment. Traineeship in a sheltered business involves an 
even stronger focus on "train-and-place" and includes 
work training in a sheltered environment, where the work 
capability of the clients is tested and tasks are adapted to 
the individual's skills and challenges.
Participants
In total, 410 participants entered the trial and were 
randomized, 56% (N=229) to the intervention group 
and 44% (N=181) to the control group (figure 1). The 
unbalanced allocation (a 2:1 randomization ratio the first 
five months of recruitment) ensured that the IPS centers 
could run according to maximal capacity.
Ethical considerations
The project was submitted to the Norwegian Regional 
Ethical Committee (REC) on 28 May 2013 (project no. 
2013/960), which found the project did not fall under the 
Health Research Act (12) and was outside the remit of 
the REC as the main outcome (competitive employment) 
was not directly health-related. The project was thereby 
exempted from evaluation and referred to the Norwegian 
Social Science Data Services, where the required per-
missions were acquired on 4 October 2013 (project no. 
34989). The research was carried out in compliance with 
the Helsinki Declaration. Personal confidentiality was 
guaranteed, and informed consent was signed by each 
participant with emphasis on the right to withdraw from 
the study at any time without any explanation.
Recruitment and randomization
The randomization procedure strictly adhered to the for-
mal requirements of adequate randomization at all times 
(11). Eligible and willing participants signed the informed 
consent and completed the baseline questionnaire. After 
randomization, participants were informed about group 
allocation. Participants in the intervention group were 
given a date for their first session, and participants in the 
control group were referred to the Norwegian Labor and 
Welfare Administration (NAV) for a prioritized spot in a 
vocational rehabilitation scheme.
Outcome measures
The primary outcome of the study was competitive 
employment rate at 12-months follow-up. Using data 
from NAV’s State Register of Employers and Employees 
(SREE), we could determine if a person was engaged 
in competitive employment, operationalized as being 
registered in the SREE, with no loss to follow-up. The 
registry gives an overview of individual employment and 
employers. Employers are required to report job spells to 
the SREE, including the day of entry and exit for each job. 
NAV records the SREE information continuously, and 
data on intervention participants was made available to 
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us for every month up until 18 months. The registry pro-
vides a conservative, yet reliable and complete measure of 
registered ordinary employment for all participants at any 
time and is more objective and accurate than self-reported 
employment or logbooks used to define the outcomes in 
most previous IPS-studies. In addition, we collected self-
reported information on competitive employment through 
questionnaires at 6- and 12-months follow-up to compare 
with previous IPS-studies.
Questionnaire-based secondary outcome measures 
were levels of psychological distress, using the Hospital 
Anxiety and Depression Scale (HADS) (13, 14); level 
of functioning, using the World Health Organization 
Disability Assessment Schedule (WHODAS) 2.0 which 
is a generic measure of functioning based on the ICF 
framework (15); frequency and severity of subjective 
health complaints, using the Subjective Health Com-
plaints Inventory (16); health-related quality of life 
(QoL), using the Euro-Qol Visual Analog Scale which is 
a vertical scale ranging from 0 (“worst imaginable health 
state”) to 100 (“best imaginable health state”) (17); and 
global well-being, using a Cantril ladder scale (18) rang-
ing from 1 (the worst life possible) to 10 (the best life 
possible). Self-report questionnaires were administered 
to the patients at baseline and after 6 and 12 months.
The Mini-International Neuropsychiatric Interview 
(MINI) 6.0.0 was administered to screen for psychiatric 
diagnoses according to criteria of the DSM-IV and ICD-
10 (19). The MINI 6.0.0. is a valid and reliable screen-
ing instrument intended for research purposes (19, 20).
Fidelity measures
The IPS-25 Fidelity Scale (21) was used to assess the 
quality of implementation. The scale measures adher-
ence to the IPS principles and has shown good predictive 
and discriminative validity in previous studies in the US 
context (21). The scale has also been used in Sweden 
(22), and the older version of the scale was used in a 
European six-center trial supporting the predictive valid-
ity in a European context (23). The psychometrics of the 
scale is yet to be formally tested in a Norwegian context 
but was used to capture fidelity and ensure comparability 
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Figure 1. Participant flow through the trial 
(CONSORT diagram).
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evaluators follow detailed instructions, and the ratings are 
done based on interviews, team meeting observations, and 
document reviews. Total score ranges from 25–125, and 
critical cutoff point for being recognized as IPS is >74 
(21). Most centers were assessed at three time points dur-
ing the project period (2014–2016). At the first measure-
ment, four of the nine teams (spread across six centers) 
were just below cutoff, but on the second and third assess-
ment, all teams scored fair (74–99 points), good (100–114 
points), or exemplary (115–125 points) on fidelity. Eight 
of the nine teams improved their fidelity scores steadily 
throughout the project period. The fidelity results will be 
described in further detail along with other process mea-
sures in a subsequent process evaluation paper.
Sample size
Our sample size calculation was based on input-data 
from previous IPS studies. In non-US studies of IPS, the 
mean competitive employment rate has been found to 
be 50% for IPS and 20% for controls (24), with studies 
in the lower range showing employment rates of 22% 
for IPS and 11% for controls (25). To identify a group 
difference given the first mean scenario, 39 participants 
in each group would be needed. Given differences in 
the lower range, 178 participants in each group would 
be needed (with a 5% significance level and power of 
80%). We assumed that our study would include a more 
heterogeneous study population than previous IPS stud-
ies, and also that the control condition on average would 
have higher quality of care. Both assumptions should 
reduce effect differentials, and we therefore planned for 
stronger statistical power and aimed to recruit 400–500 
participants [for details, see the protocol paper (11)].
Statistical analysis
For the main effect analysis, we observed crude employ-
ment rates of participants in the two groups. In separate 
multiple linear regression analyses, we also examined 
effects of the intervention including adjustment for group 
differences in age, gender, calendar year and month, 
and site indicators. This alternative approach did not 
yield any noteworthy changes in results. The effects of 
IPS on secondary outcomes were examined using mul-
tiple mixed-effects regression analyses with maximum 
likelihood estimation. Estimated marginal means, with 
95% confidence intervals (CI), were based on the mixed 
effects regression models. Self-reported employment 
was adjusted for non-response using inverse probability 
weights (IPW). The IPW were calculated based on logis-
tic regression models adjusting for variables predicting 
non-response, with a P-value of <0.10. Analyses adhered 
to the “intention-to-treat” principle. To test for potential 
subgroup effects of IPS, an analysis of the prespecified 
subgroups "moderate versus severe mental illness" was 
conducted (11). The author in charge of the data analysis 
was blinded for intervention assignment. Data were ana-
lyzed using the statistical package StataIC (Stata Corp, 
College Station, TX, USA) version 14 and 15.
Results
Figure 2 outlines the main outcome measure, competitive 
employment rate, for each month. Data on this outcome 
measure were complete for all participants up to 18 
months post-inclusion. However, for secondary outcomes 
based on self-report, 47% of the participants at 6-months 
follow-up, and 44% of the participants at 12-months 
follow-up returned their questionnaires (see figure 2).
Participant characteristics
Psychiatric screening. MINI 6.0.0 was administered at 
baseline and showed that depression as well as anxiety 
and psychotic disorders were the most common diagnoses 
(table 1). In total, 45% (N=136) of the participants ful-
filled the criteria for what previous IPS trials have defined 
as severe mental illness (ie, psychotic or bipolar disorder 
with or without comorbid substance abuse/dependency), 
while 55% (N=164) were categorized as moderate mental 
illness (primarily affective disorders).
Primary outcome measure
Registry data from the SREE provided objective and 
direct indicators of work participation: start and stop 
dates for participants’ work engagements, retrieved 
monthly during the full time-frame of the trial. Informa-
tion on benefits, such as work assessment allowances 
Figure 2.  Average employment rates in both groups. Development over 
time from 44 months prior to inclusion up to 18 months after inclusion.
1 In separate multiple linear regression analyses we also examined effects of the intervention
including adjustment for group differences in age, gender, calendar year, calendar month, and
site indicators. This alternative approach did not yield any noteworthy hanges of results.
2 If we consider the subsample of employed individuals at 18 months, sickness absence is
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(WAA), disability benefits or unemployment benefits, 
were added to gain more detailed information on the 
participants’ degree of work participation.
There could be incomplete registrations of both 
new and terminated jobs in the SREE registry, but this 
measurement error should be non-differential for the 
intervention and control group. With that assumption, 
the measurement error should not bias estimates, but 
make it harder to demonstrate any true effect of the inter-
vention. In certain cases, jobs appeared to have ceased 
without a registered stop-date. As table 2 shows, about 
19% of the participants were registered as employed at 
baseline, and, as expected, the proportion is very similar 
in the treatment and control groups. Many of these 76 
individuals had a weak attachment to the labor market at 
inclusion, eg, 11 were sick-listed, 32 combined job and 
WAA, and 8 were on graded disability benefits.
Table 2 shows an increase in participants receiving 
disability benefits in both the control and the interven-
tion group over time. This tendency was also observed 
for recipiency of WAA from inclusion up to 12 months. 
There was however also an increase in the proportion of 
participants who were working. These two categories, 
work participation and receiving WAA, are not mutu-
ally exclusive. For instance, a person may be able to 
work 50% and receive disability pension or WAA for 
the remaining 50%. At 18-months follow-up, there was 
a larger share of sick-listed participants in the IPS than 
the control group. This should be expected given that 
employment (which is a requirement for sick-listing) 
was more common in the IPS group at 18 months. [If 
we consider the subsample of employed individuals at 
18 months, sickness absence is more frequent in the IPS 
than the control group, but the difference is not statisti-
cally significant.] Results show a large increase in the 
proportion of participants in competitive employment 
in the IPS group (figure 2). While the proportion of 
employed participants was similar in the two groups at 
inclusion, there was a difference in favor of the inter-
vention group of 9.5 percentage points (proportions are 
36.6 versus 27.1) at 12-months follow-up.
Table 3 presents the results from the subgroup analy-
sis of diagnostic groups (moderate versus severe mental 
illness). While the proportion of employed participants 
was slightly higher in the group with moderate mental 
illness at baseline, both groups showed a similar effect 
of IPS on competitive employment at 12- and 18-months 
follow-up. The tests of comparison within each subgroup 
did not reach statistical significance, probably due to an 
insufficient number of participants in the two subgroups.
Self-reported employment
In the unadjusted analyses of self-reported employment, 
a significantly higher proportion in the IPS group (43%) 
Table 1. Demographic and clinical characteristics at baseline. 
[SD=standard deviation; IPS=individual placement & support]
Variable Control IPS P-value a
N % Mean SD N % Mean SD
Age at 
inclusion
34.92 10.78 35.11 10.77 0.858
Years of 
illness
11.49 9.55 10.42 8.90 0.302
Gender 
(female)




45 25.3 43 19.2 0.143
Country of 
birth (Norway)
157 86.7 196 85.6 0.738
Higher educa-
tion (yes) b








43 24.2 60 27.6 0.432
Psychiatric 
diagnoses c
Psychotic 46 41.4 65 58.6 0.732
Bipolar 15 26.3 42 73.7 0.006
Major 
depression
67 40.9 97 59.1 0.564
Anxiety 65 39.2 101 60.8 0.232
Alcohol/drug 
abuse
36 48.0 39 52.0 0.279
Other 11 32.4 23 67.6 0.202
a Comparison of study groups using chi square tests for categorical variables, 
independent t-tests for continuous variables.
b Self-reported completed university/university college education.
c Numbers and proportions exceed total number and 100% as participants 
could meet criteria for more than one diagnosis
reported to have been in competitive employment com-
pared to the control group (27%) during the past 12 
months (P=0.013). When adjusted for non-response using 
IPW, the self-reported employment rates changed to 41% 
and 28% for the IPS and control group respectively. The 
difference was still statistically significant (P=0.038).
Secondary outcome measures
The IPS group reported significant improvements in 
psychological distress, symptoms of depression, subjec-
tive health complaints, functioning, health-related QoL, 
and global well-being, compared to the control group at 
12-months follow-up (table 4).
Missing data
Missing data on the secondary outcomes were adjusted in 
mixed effects regression models, using maximum likeli-
hood estimation (MLE). Possible systematic differences 
between those who responded to questionnaires at 6- and 
12-months follow-up and those who did not, were inves-
tigated by comparing baseline characteristics. Results 
showed that non-responders reported better function, 
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Table 2. Competitive employment and benefit recipiency at inclusion, 12-, and 18-month follow-up. [IPS=individual placement & support.]














Mean a Mean a Mean a Mean a Mean a Mean a
Employment 0.188 0.185 0.942 0.271 0.366 0.042 0.271 0.374 0.027
Sick-leave 0.072 0.048 0.320 0.022 0.044 0.227 0.022 0.070 0.025
Disability pension 0.122 0.119 0.936 0.144 0.145 0.961 0.160 0.159 0.964
Work assessment allowance (WAA) 0.547 0.502 0.370 0.613 0.564 0.316 0.569 0.529 0.416
WAA and employment 0.099 0.062 0.159 0.127 0.172 0.212 0.110 0.167 0.102
Unemployment benefits 0.022 0.053 0.112 0.033 0.031 0.895 0.028 0.035 0.664
Social security benefits 0.166 0.163 0.941 0.099 0.101 0.950 0.102 0.090 0.732
a Percentages/100.
Table 3. Subgroup analysis of participants with severe mental illness (psychotic or bipolar disorders) and moderate mental illness (primarily affective 
disorders). Competitive employment at inclusion, 12-, and 18-month follow-up. [IPS=individual placement & support.]
Employment Baseline (at inclusion) 12-month follow-up 18-month follow-up
Control IPS P-value Control IPS P-value Control IPS P-value
N Mean a N Mean a N Mean a N Mean a N Mean a N Mean a
Severe mental illness 51 0.157 85 0.118 0.517 51 0.235 85 0.353 0.153 51 0.255 85 0.388 0.113
Moderate mental illness 76 0.211 88 0.193 0.784 76 0.276 88 0.375 0.182 76 0.263 88 0.375 0.128
a Percentages/100.
Table 4a. Health and well-being. Mean scores at baseline and 6-month follow-up. Adjusted for baseline and missing data. [CI=confidence interval; 
HADS=Hospital Anxiety and Depression Scale; SHC=subjective health complaints; WHODAS=World Health Organization Disability Assessment 
Schedule; QoL=quality of life.]
Scale Group Baseline 6-month follow-up
Mean (95% CI) Mean (95% CI) Difference (95% CI) P-value Effect size (95% CI)
HADS Total (0–42) IPS 15.97 (14.97–16.97) 20.64 (19.28–22.01) 0.36 (-1.75–2.47) 0.737 0.05 (-0.24–0.34)
Control 16.13 (15.00–17.25) 20.28 (18.66–21.91)
HADS Anxiety (0–21) IPS 9.02 (8.44–9.60) 11.00 (10.18–11.83) 0.42 (-0.86–1.71) 0.517 0.10 (-0.20–0.40)
Control 9.15 (8.51–9.79) 10.58 (9.59–11.56)
HADS Depression (0–21) IPS 6.88 (6.34–7.43) 9.64 (8.94–10.34) -0.07 (-1.13–0.99) 0.896 -0.02 (-0.28–0.24)
Control 6.98 (6.38–7.58) 9.71 (8.88–10.54)
SHC Severity (0–87) IPS 14.23 (12.87–15.60) 15.02 (13.41–15.65) -2.18 (-4.40–0.04) 0.054 -0.20 (-0.41–0.003)
Control 15.09 (13.51–16.67) 17.20 (15.35–19.05)
WHODAS Disability (0–100) IPS 22.47 (20.48–24.46) 22.57 (19.68–25.46) -1.63 (-6.03–2.78) 0.469 -0.10 (-0.38–0.17)
Control 23.48 (21.14–25.82) 24.20 (20.69–27.70)
Health-related QoL (0–100) IPS 58.63 (56.12–61.14) 58.86 (55.02–62.52) 3.28 (-2.14–8.69) 0.236 0.16 (-0.11–0.43)
Control 57.66 (54.41–60.91) 55.58 (51.36–59.80)
Global well-being (1–10) IPS 4.73 (4.50–4.96) 5.12 (4.80–5.44) 0.44 (-0.04–0.92) 0.071 0.24 (-0.02–0.50)
Control 4.86 (4.56–5.16) 4.67 (4.29–5.05)
Table 4b. Health and well-being. Mean scores at 12-month follow-up. Adjusted for baseline and missing data. [CI=confidence interval; 
HADS=Hospital Anxiety and Depression Scale; SHC=subjective health complaints; WHODAS=World Health Organization Disability Assessment 
Schedule; QoL=quality of life.]
Scale Group Baseline 12-month follow-up
Mean (95% CI) Mean (95% CI) Difference (95% CI) P-value Effect size (95% CI)
HADS Total (0–42) IPS 15.97 (14.97–16.97) 13.74 (12.38–15.09) -3.00 (-5.13–-0.87) 0.006 -0.41 (-0.70–-0.12)
Control 16.13 (15.00–17.25) 16.74 (15.09–18.39)
HADS Anxiety (0–21) IPS 9.02 (8.44–9.60) 8.08 (7.26–8.90) -1.19 (-2.48–0.11) 0.072 -0.29 (-0.58–0.02)
Control 9.15 (8.51–9.79) 9.27 (8.27–10.27)
HADS Depression (0–21) IPS 6.88 (6.34–7.43) 5.65 (4.96–6.35) -1.85 (-2.91–-0.78) 0.001 -0.46 (-0.72–-0.19)
Control 6.98 (6.38–7.58) 7.50 (6.66–8.34)
SHC Severity (0–87) IPS 14.23 (12.87–15.60) 14.13 (12.52–15.73) -2.79 (-4.99–-0.58) 0.013 -0.26 (-0.46–-0.05)
Control 15.09 (13.51–16.67) 16.91 (15.07–18.75)
WHODAS Disability (0–100) IPS 22.47 (20.48–24.46) 19.60 (16.81–22.4) -9.09 (-13.3–-4.87) <0.001 -0.57 (-0.83–-0.30)
Control 23.48 (21.14–25.82) 28.70 (25.34–32.05)
Health-related QoL (0–100) IPS 58.63 (56.12–61.14) 60.79 (57.19–64.38) 7.38 (1.89–12.86) 0.008 0.37 (0.09–0.64)
Control 57.66 (54.41–60.91) 53.41 (49.04–57.77)
Global well-being (1–10) IPS 4.73 (4.50–4.96) 5.32 (4.99–5.64) 0.63 (0.14–1.11) 0.012 0.34 (0.08–0.61)
Control 4.86 (4.56–5.16) 4.69 (4.30–5.08)
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less subjective health problems and fatigue, better health-
related QoL and more problems with substance abuse at 
baseline. There were no indications of a differentiated pat-
tern of drop-out between the IPS and control groups. Due 
to practical difficulties, the psychiatric interviews (MINI) 
were not administered to all participants. However, we 
have no reason to believe that there were any systematic 
patterns in the missing interviews.
Discussion
The primary aim of this trial was to investigate whether 
IPS resulted in a higher rate of competitive employment 
compared to high quality usual care among people with 
moderate-to-severe mental illness in a societal context 
characterized by high job security, low unemployment, 
and a comprehensive welfare system. At 12-months 
follow-up, registry data revealed that 36.6% of partici-
pants in the IPS group and 27.1% of participants in the 
control group were in competitive employment, while 
the difference was slightly higher (37.4% versus 27.1%) 
at 18-months follow-up. Furthermore, a subgroup analy-
sis showed that the employment rates were similar in 
participants with moderate and severe mental illness, 
which indicates that IPS has an effect beyond the origi-
nal target group of patients with severe mental illness.
The secondary aims of the trial involved investigat-
ing potential effects of IPS on psychological distress, 
symptoms of depression, and improvements in health 
complaints, functioning, health-related QoL, and gen-
eral well-being. IPS yielded positive effects on all the 
secondary outcomes compared to the control condition.
Study context
The present results need to be interpreted with regard to 
study context. The Norwegian welfare regime is more 
extensive and also provides higher financial reimburse-
ments than most welfare systems (26). Moreover, an 
important characteristic of the Norwegian labor market is 
relatively strong employment protection legislation (27) 
leading to high job security. There is reason to believe that 
a higher level of job security is a challenge for employ-
ment specialists regarding employers’ willingness to hire. 
Norway is a small, open economy, where many firms are 
exposed to international competition. As in other Nordic 
welfare states, the unemployment rate is low but the wage 
structure is rather compressed, which considerably limits 
the demand for low productivity labor. Of all OECD 
countries, Norway has the highest sickness absence rates 
and financial expenses due to absence from working life 
(26). Such contextual factors might reduce the potential 
for effects of interventions to increase work participation 
and could thereby strengthen the salience of the observed 
effect of IPS on work participation in the present study.
Comparison with international IPS trials
The effect of IPS on work participation among people 
with severe mental illness has a large and growing evi-
dence base in 23 RCT studies worldwide so far (8). The 
majority of these were conducted in various US states, 
but several have emerged from European and Eastern 
countries in the last decade. IPS trials with high model 
adherence have in a meta-analysis demonstrated employ-
ment rates of 61% as compared to 23% in groups receiv-
ing traditional rehabilitation programs (7). These rates 
are primarily based on IPS trials in the USA, which on 
average show greater effect on employment than studies 
from other western countries (24). In a large European 
trial involving six different countries, 55% of IPS par-
ticipants and 28% of control group participants receiving 
traditional work rehabilitation programs gained employ-
ment (28). In four of these six countries (England, Italy, 
Switzerland and Bulgaria) IPS was more effective than 
the traditional work rehabilitation programs offered. In 
the other two countries, Germany and the Netherlands, 
no statistically significant differences were found between 
IPS and control groups. The authors suggested work char-
acteristics, policies and the welfare regimes in these two 
countries explained the lack of an effect. Only one RCT 
has previously evaluated the effect of IPS for people with 
severe mental illness in Scandinavia. The Swedish study 
(29) showed a significant effect of IPS on employment at 
18-month follow-up, with 46% of the IPS-group partici-
pants employed compared to 11% in the control group.
Despite the statistically significant and robust results 
from the current trial, our rates of competitive employ-
ment are lower than in most previous IPS trials. One 
possible explanation could relate to our somewhat dif-
ferent inclusion criteria compared to those used in previ-
ous trials. We included a broader group of participants 
by allowing patients with any psychiatric disorder to 
be included, and not only patients with a psychotic or 
bipolar disorder like in most previous IPS trials. Still, 
the subgroup analysis demonstrated similar employment 
rates in the two subgroups, indicating that the inclusion 
criteria did not influence employment rates substantially.
Another, more credible, explanation for the some-
what lower employment rate is our primary outcome 
data and definition. All previous IPS trials have assessed 
employment outcomes using self-report from partici-
pants and/or logbooks, with threshold values varying 
from one hour to one day of employment throughout 
the whole follow-up period. In contrast, by using regis-
try data from the SREE, employments not expected to 
exceed NOK1000 (approximately EUR105) per year per 
employer will not be subject to notification. Minor jobs 
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below this threshold will therefore not be registered. 
Further exceptions apply to freelance and self-employ-
ment. This implies a comparatively stricter definition of 
work than in previous trials based on self-report. A main 
advantage of registry data is its objectivity. Registry data 
also secures information from all participants over the 
entire duration of the trial. Compared to the relatively 
high drop-out rates when relying on self-report, this 
removes an important source of attrition bias.
In order to compare results more directly with previ-
ous international studies, we also included self-reported 
employment. Corresponding with the results from the 
registry data, participants receiving IPS reported consid-
erably higher employment rates compared to the control 
group, but rates using self-reported data were higher.
The control group in the current study was found to 
have a higher competitive employment rate than most 
international IPS trials. This could be partly due to the 
quality of services provided to control group participants. 
Not only were services provided to the control group a 
high-quality version of usual care, which included priori-
tized access to traditional employment services, but there 
may also have been a "spillover-effect" from IPS into the 
services providing vocational rehabilitation to the control 
group. This trial was conducted in 6 of 19 Norwegian 
counties, and was among the largest IPS trials worldwide. 
Moreover, the awareness of IPS and its impact on work 
participation found in international studies increased 
among service providers during the timeframe of this 
trial. It cannot be ruled out that those providing work 
rehabilitation services to the control group may have 
incorporated elements from IPS in their services and that 
this has had an impact on their results.
Strengths and limitations
The main strength of the study is the multicenter RCT 
design and the large sample size, providing robust, com-
plete and objective outcome data on the effect of the 
intervention as deployed in an ecologically valid setting. 
The research group was not involved in running the sites 
or the patient treatment, which ensured an independent 
evaluation. All the IPS centers scored consistently high on 
fidelity, yet the scores differed somewhat between centers. 
The fidelity assessments revealed an increase in fidelity 
throughout the trial. Alongside the trial, an extensive 
process evaluation was carried out to investigate imple-
mentation quality, barriers and facilitators, contextual 
factors and the participants' experiences. These findings 
will be published in a subsequent paper. Limitations of 
the study include inaccurate information on hours worked 
and the relatively high loss to follow-up on self-reported 
outcomes. The latter was, however, mitigated by applying 
maximum likelihood estimation (MLE) and IPW in the 
analyses of self-reported outcomes.
Implications
In line with recent OECD recommendations (26), the 
IPS program integrates mental healthcare and rehabilita-
tion services and incorporates a focus on both work and 
health. The IPS trial was uniquely co-commissioned by 
the Norwegian health and welfare authorities as part of 
a national initiative to implement IPS on a large scale. 
The experience of successful collaboration between 
academic researchers and policymakers, where a novel 
policy scheme and intervention underwent rigorous 
scientific evaluations before large-scale implementation, 
has important policy implications and should inspire fur-
ther use of trials in this sector. Beyond strengthening the 
evidence base, such collaborations can help bridge the 
gap between knowledge and practical application (30).
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